Tevogen Bio Holdings Inc. TVGN
5.92 USD +0.33 (+5.90%)
At closeNov 3, 2026, 4:02 PM EST
5.92 0.00 0.00%
After hours · Nov 3, 4:02 PM ET
5.51 Day range 6.01
3.64 52-week range 32.50
- YTD
- -64.23%
- 1 year
- -79.86%
Financial health
Altman Z-Score
-59.61 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.0×
FY 2021 5y median -11.0× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -6.7×
FY 2021 5y median -22.6× FY 2025
P/FCF -4.4×
FY 2021 5y median -88.5× FY 2025
EV/EBITDA -2.2×
FY 2021 5y median -11.6× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -22.5%
FY 2021 5y median -1.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 319.1%
FY 2021 5y median 94.6% FY 2025
ROIC 3698.7%
FY 2021 5y median -15.7% FY 2025
ROA -599.5%
FY 2021 5y median -292.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income 51.2%
FY 2021 FY 2025
EPS (diluted) -72.6%
FY 2021 FY 2025
Free Cash Flow -3.3%
FY 2021 FY 2025
Financial Health
Current Ratio 0.2×
FY 2021 5y median 0.3× FY 2025
Quick Ratio 0.2×
FY 2021 5y median 0.3× FY 2025
Debt / Equity -0.4×
FY 2021 5y median -1.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2021 5y median -0.1× FY 2025
Interest Coverage -134×
FY 2021 5y median -34.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31